FINACEA FOAM
- Product NDC
- 50419-829
- 11-digit product format
- 504190829
- Labeler code
- 50419
- Product ID
- 50419-829_b23e5be7-91a5-4981-839c-655615884b21
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- azelaic acid
- Dosage form
- AEROSOL, FOAM
- Route
- TOPICAL
- Labeler
- Bayer HealthCare Pharmaceuticals Inc.
- Application
- NDA207071
- Marketing category
- NDA
- Marketing start
- 2015-08-03
- Marketing end
- 0000-00-00
- Substance
- AZELAIC ACID
- Active strength
- 0 g/g
- Pharmacologic classes
- Decreased Protein Synthesis [PE],Decreased Sebaceous Gland Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50419-829-01 | 2023-01-30 | C162847 | 48780-1 | ba0f9c33-1d7e-a910-e053-dadaa90a0b85 | d3f44051-9a13-4bcf-9783-f09286d86f4f |
| 50419-829-71 | 2023-01-30 | C162847 | 48780-1 | ba0f9c33-1d7e-a910-e053-dadaa90a0b85 | d3f44051-9a13-4bcf-9783-f09286d86f4f |
| 50419-829-72 | 2023-01-30 | C162847 | 48780-1 | ba0f9c33-1d7e-a910-e053-dadaa90a0b85 | d3f44051-9a13-4bcf-9783-f09286d86f4f |
| 50419-829-01 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-1d7e-a910-e053-dadaa90a0b85 | d3f44051-9a13-4bcf-9783-f09286d86f4f |
| 50419-829-71 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-1d7e-a910-e053-dadaa90a0b85 | d3f44051-9a13-4bcf-9783-f09286d86f4f |
| 50419-829-72 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-1d7e-a910-e053-dadaa90a0b85 | d3f44051-9a13-4bcf-9783-f09286d86f4f |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50419-829-01 | GM - Gram | 50419-829 | 66d6ff59-5cd4-4d01-b8ff-74f1b222b2c4 | 1 | 2015-09-10 |